Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 5

Results: 25

Atomoxetine hydrochloride.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 385, doi. 10.1038/nrd1387

By:

Garland, Melissa;
Kirkpatrick, Peter

Publication type:

Article

INFLAMMATORY RESOLUTION: NEW OPPORTUNITIES FOR DRUG DISCOVERY.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 401, doi. 10.1038/nrd1383

By:

Gilroy, Derek W.;
Lawrence, Toby;
Perretti, Mauro;
Rossi, Adriano G.

Publication type:

Article

NEW HORIZONS IN CHEMICAL SPACE.

Published in:: 2004
Publication type:: Editorial

Current and future applications of the capsule camera.

Published in:

2004

By:

Qureshi, Waqar A.

Publication type:

review

Prospects for productivity.

Published in:

2004

By:

Booth, Bruce;
Zemmel, Rodney

Publication type:

research

Monoclonal antibodies market.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 383, doi. 10.1038/nrd1386

By:

Reichert, Janice;
Pavlou, Alex

Publication type:

Article

FDA HEAD WANTED, WIMPS NEED NOT APPLY.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 459, doi. 10.1038/nrd1396

By:

Miller, Henry I.

Publication type:

Article

KEY FACTORS IN THE RISING COST OF NEW DRUG DISCOVERY AND DEVELOPMENT.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 417, doi. 10.1038/nrd1382

By:

Dickson, Michael;
Gagnon, Jean Paul

Publication type:

Article

DEVELOPMENT OF NOVEL TARGETED THERAPIES IN THE TREATMENT OF MALIGNANT GLIOMA.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 430, doi. 10.1038/nrd1380

By:

Rich, Jeremy N.;
Bigner, Darell D.

Publication type:

Article

Timing is everything.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 387, doi. 10.1038/nrd1397

By:

Ellis, Clare

Publication type:

Article

Metabolite-mediated misfolding.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 390, doi. 10.1038/nrd1391

By:

Farley, Suzanne

Publication type:

Article

DISCOVERY AND DEVELOPMENT OF BEVACIZUMAB, AN ANTI-VEGF ANTIBODY FOR TREATING CANCER.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 391, doi. 10.1038/nrd1381
Publication type:: Article

IN BRIEFS.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 390
Publication type:: Article

New use for the cellular dustbin.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 389, doi. 10.1038/nrd1389

By:

Kirkpatrick, Peter

Publication type:

Article

Plumbing for the heart.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 388, doi. 10.1038/nrd1392

By:

Owens, Joanna

Publication type:

Article

Patent office decision over restriction requirement scrutinized.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1393
Publication type:: Article

Zebrafish reduce drug discovery gridlock.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 388, doi. 10.1038/nrd1398

By:

Brazil, Melanie

Publication type:

Article

AN AUDIENCE WITH ... Allen D. Roses.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 382, doi. 10.1038/nrd1400
Publication type:: Article

Patentability in the United States.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 381, doi. 10.1038/nrd1388

By:

Fashena, Sarah J.;
Jackson, David A.

Publication type:

Article

Chiron claims against Genentech patent dismissed again.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1394
Publication type:: Article

No commercial break for combination treatment.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 380, doi. 10.1038/nrd1390
Publication type:: Article

FDA publishes analysis of the pipeline problem.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 379, doi. 10.1038/nrd1404

By:

Frantz, Simon

Publication type:

Article

NEWS IN BRIEF.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 378
Publication type:: Article

Expanded EU presents promise and challenges.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 5, p. 377, doi. 10.1038/nrd1403
Publication type:: Article

AMP KINASE AND MALONYL-COA: TARGETS FOR THERAPY OF THE METABOLIC SYNDROME.

Published in:: 2004
Publication type:: Correction Notice